Medicare launched a $50-per-month GLP-1 program on July 1, 2026. If you've been watching the forums, you've seen the questions pile up: "Do I qualify?" "My doctor said no — why?" "What about compounded?" "I'm 45 — is this even for me?"

The confusion is real. The program has real gates. And for most people asking those questions, the answer is more complicated than the headlines suggest.

Here is the clearest breakdown we can give you.

What Is the Medicare GLP-1 Bridge?

The Medicare GLP-1 Bridge is a CMS (Centers for Medicare and Medicaid Services) program that covers a set of brand-name GLP-1 medications for eligible Medicare beneficiaries at a $50 monthly copay through December 2027.

The "Bridge" framing refers to a temporary coverage mechanism — an on-ramp while permanent Medicare GLP-1 coverage is still being worked through legislation.

Which Drugs Are Covered?

As of July 2026, the Bridge covers three FDA-approved brand medications through Medicare Part D: all formulations of Foundayo (orforglipron), all formulations of Wegovy (injection and oral tablet), and the KwikPen formulation of Zepbound — Zepbound's single-dose vial and single-dose pen are not covered. The copay is $50 per 30-day supply. Compounded GLP-1 medications are not part of the Bridge program — the covered list includes only FDA-approved brand-name drugs. That is how CMS designed the program, not a clinical judgment about compounded medications. CMS can update the covered list, so check the current version at cms.gov.

Who Qualifies?

This is where most of the confusion lives. The Bridge has layered eligibility gates:

Gate 1 — Medicare enrollment. You must be enrolled in Medicare Part D. If you are under 65 and not on Medicare for another reason (disability, ESRD), the Bridge does not apply to you.

Gate 2 — BMI thresholds. Eligibility is assessed as of when you started GLP-1 therapy, through one of three pathways: a BMI of 35 or higher on its own; a BMI of 30 or higher with heart failure (preserved ejection fraction), uncontrolled high blood pressure despite two medications, or chronic kidney disease (stage 3a or above); or a BMI of 27 or higher with pre-diabetes, a prior heart attack, a prior stroke, or symptomatic peripheral artery disease.

Gate 3 — Already covered elsewhere. The Bridge is only for people using a GLP-1 solely for weight reduction or weight maintenance. If your GLP-1 already qualifies for regular Part D coverage for another use — type 2 diabetes, moderate-to-severe obstructive sleep apnea, noncirrhotic MASH (metabolic dysfunction-associated steatohepatitis), or cardiovascular-risk reduction — you are not eligible for the Bridge; you keep getting the medication through your regular Part D plan.

Gate 4 — Brand-name drug requirement. Your prescription must be for a covered brand-name medication. If your provider prescribes a compounded version or a non-covered drug, the $50 copay does not apply.

Why So Many People Don't Qualify

Most people actively searching for GLP-1 help are not Medicare beneficiaries. The cash-pay D2C market — the people using telehealth platforms, paying out of pocket, looking at compounded options — is predominantly under 65.

Even among Medicare beneficiaries, the BMI and comorbidity gates knock out a meaningful share. And the already-covered-elsewhere rule creates real confusion: someone who manages their weight alongside type 2 diabetes may find their GLP-1 coverage falls under a different part of Medicare entirely.

The $50 number is real. For the people who meet every gate, it is a genuine relief. For everyone else — which is most of the people asking — it is not accessible.

What to Do If You Don't Qualify

If you do not qualify for the Bridge (or you are not a Medicare beneficiary at all), you are the person the supervised cash-pay model was built for — no insurance gates, no benefits paperwork, a real clinical process instead of a coverage decision.

That is exactly what Nuvari does: we connect you with independent, licensed physicians who review your health picture and, when clinically appropriate, build a physician-directed weight-management protocol around your goals — dispensed by licensed US pharmacies, with ongoing check-ins and dosing supervision.

The difference worth caring about is supervision. A legitimate program follows you — labs, check-ins, dose adjustments — rather than sending a questionnaire and a shipment and disappearing. That standard is the bar Nuvari was built to clear.

Take the free assessment — it takes about two minutes, and it is the fastest way to see what your path looks like outside of Medicare.

FAQ Section

Is compounded semaglutide covered by the Medicare GLP-1 Bridge?

No. The Medicare GLP-1 Bridge covers three brand-name GLP-1 medications through Medicare Part D only; compounded medications are not on the covered list. That reflects how CMS designed the program, not a clinical judgment about compounded medications.

I'm under 65. Does the Medicare Bridge apply to me?

Generally no. The Bridge is a Medicare Part D program. If you are under 65 and not enrolled in Medicare (some people under 65 qualify due to disability), the program does not apply to you. The supervised cash-pay model — what Nuvari is built on — is the primary pathway for people under 65 seeking physician-directed GLP-1 programs. Take the free assessment to get started.

What BMI do I need to qualify for the Medicare Bridge?

There are three pathways, assessed as of when you started GLP-1 therapy: a BMI of 35 or higher on its own; a BMI of 30 or higher with heart failure, uncontrolled high blood pressure, or chronic kidney disease (stage 3a or above); or a BMI of 27 or higher with pre-diabetes, a prior heart attack, a prior stroke, or symptomatic peripheral artery disease. Your prescriber can confirm how your specific profile maps to eligibility.

Why does my doctor say I don't qualify even though I've heard about the $50 GLP-1 program?

Several common reasons: you may not be enrolled in Medicare Part D; your BMI may not meet the threshold; you may have a condition (like type 2 diabetes or sleep apnea) that routes your coverage through a different Medicare mechanism; or your provider may have prescribed a medication or formulation that is not on the Bridge's covered-drug list. Ask your provider to walk through the specific gate that applies to your situation.

If I don't qualify for the Bridge, what is my best option?

For most people outside the Bridge's eligibility gates, the most direct path is a supervised cash-pay program. Nuvari connects you with independent, licensed physicians who review your health picture and build a physician-directed program around it — start with the free assessment.